Simplex Trading’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$543K Buy
16,300
+10,300
+172% +$346K ﹤0.01% 3156
2025
Q4
$207K Buy
6,000
+4,700
+362% +$150K ﹤0.01% 4206
2025
Q3
$35K Sell
1,300
-7,400
-85% -$179K ﹤0.01% 6815
2025
Q2
$182K Buy
8,700
+2,900
+50% +$55.6K ﹤0.01% 4607
2025
Q1
$95K Buy
5,800
+4,600
+383% +$98K ﹤0.01% 5104
2024
Q4
$30K Sell
1,200
-2,600
-68% -$73.6K ﹤0.01% 6353
2024
Q3
$120K Buy
3,800
+2,500
+192% +$94.8K ﹤0.01% 5045
2024
Q2
$45K Sell
1,300
-700
-35% -$27.7K ﹤0.01% 6194
2024
Q1
$87K Buy
2,000
+300
+18% +$12.9K ﹤0.01% 5730
2023
Q4
$60K Sell
1,700
-2,300
-58% -$68.7K ﹤0.01% 5915
2023
Q3
$107K Buy
4,000
+1,800
+82% +$45.6K ﹤0.01% 5015
2023
Q2
$51K Buy
2,200
+1,800
+450% +$37K ﹤0.01% 5823
2023
Q1
$5K Sell
400
-3,100
-89% -$51.6K ﹤0.01% 8045
2022
Q4
$63K Sell
3,500
-800
-19% -$13.5K ﹤0.01% 5581
2022
Q3
$64K Buy
4,300
+700
+19% +$9.09K ﹤0.01% 6097
2022
Q2
$49K Buy
+3,600
New +$40K ﹤0.01% 6515
2022
Q1
Sell
-7,300
Closed -$172K 10838
2021
Q4
$172K Buy
7,300
+6,800
+1,360% +$158K ﹤0.01% 5405
2021
Q3
$10K Hold
500
﹤0.01% 8919
2021
Q2
$10K Buy
500
+499
+49,900% +$10.3K ﹤0.01% 9089
2021
Q1
$2K Buy
+1
New +$19 ﹤0.01% 8456

Other funds holding IDYA

Simplex Trading's IDYA Position: Q1 2026 in Review

Simplex Trading sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 2,862 shares — an estimated $96K sold.

Simplex Trading first reported a position in IDYA in Q1 2023 and held it in 5 quarters. The position peaked at $98.9K in Q4 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Simplex Trading reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 2,862 IDEAYA Biosciences shares in Q1 2026, an estimated $96K.
  • Simplex Trading first reported a position in IDEAYA Biosciences in Q1 2023 and held it in 5 quarters.
  • Simplex Trading's IDEAYA Biosciences position peaked at $98.9K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.